Jyothy Labs Limited has informed the Exchange about Schedule of meet
JYOTHYLAB · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Jyothy Labs has informed the stock exchanges about a scheduled investor/analyst meeting under SEBI's Listing Obligations and Disclosure Requirements. The meeting is a one-on-one session with Nippon India Mutual Fund, planned for March 4, 2026. The company has clarified that no Unpublished Price Sensitive Information (UPSI) will be shared during the meeting. The latest investor presentation is available on the company's website. The filing was signed by Shreyas Trivedi, Head – Legal & Company Secretary, and is a routine compliance disclosure.
This is a standard regulatory disclosure with no direct impact on the stock price. It reflects ongoing institutional engagement by the company with major mutual funds, which is generally viewed as a neutral-to-positive sign of investor relations activity.